MOMasatsugu Okamura

Masatsugu Okamura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masatsugu Okamura has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Scoping review of return to work in patients with heart failure

    by Shuri Nakao, Hidehiro Someko, Masatsugu Okamura, Yasushi Tsujimoto, Tomohiko Kamo, Hirofumi Ogihara, Shinya Sato, Sokichi Maniwa

    Heart failure (HF) has a significant impact on quality of life and employment. For patients with HF of work age, return to work (RTW) is an important goal because of its social and economic significance. This scoping review aimed to investigate the definition of RTW, RTW rates, support programs, and factors associated with RTW in patients with HF, and to propose future research and clinical support strategies. We included 47 studies with 64,048 individuals: 21 cohort studies (five prospective studies, 16 retrospective studies), three cross sectional studies, three case series studies (two retrospective studies, one prospective study), 18 case reports, two qualitative studies. Participants were aged 18–65 years old and were employed prior to a diagnosis of HF. Only one study defined RTW in patients with HF, and it was described as “whether or not patients were working for income.” The overall RTW rate across the studies had a median of was 56.0%, (interquartile range 25.8–100.0%, range 0.0–100.0%) but the rate varied across studies. Support programs were reported in two studies as rehabilitation and in one study as paid leave. The facilitating and inhibiting factors of RTW were classified into medical factors (e.g., ejection fraction, comorbidities), social determinants of health (e.g., education, income), and employment or work-related factors (e.g., job type, work ability). Future research needs to consider the results of this scoping review, particularly the ambiguity in the definition of RTW and the facilitating and inhibiting factors identified.

  • Spin in Systematic Reviews of Rehabilitation Journals Was High Prevalence

    by Takahiro Tsuge, Norio Yamamoto, Yosuke Tomita, Akikazu Hagiyama, Daijo Shiratsuchi, Masatsugu Okamura, Takao Kaneko, Kosuke Suzuki, Yuki Nakashima, Shunsuke Taito, et al.

    Objectives: Systematic reviews are crucial for evidence-based medicine, but authors may add spin. This study investigated the prevalence of spin in abstracts and main texts of systematic reviews published in rehabilitation journals and explored associated factors. Design: This meta-epidemiological study secondary analysis 200 systematic reviews from rehabilitation journals (2020–2022) focusing on pairwise meta-analyses of health interventions. Two independent reviewers extracted data. Spin was defined as reporting that highlights a beneficial effect greater than shown by results. We classified spin into misleading reporting, misleading interpretation, inappropriate extrapolation, and multiple spins based on analysis of the main text and Results: Spin was present in 154 (77.0%) systematic reviews in the main text and 151 (75.5%) in the Misleading interpretation was the most common category (86.4% in main text, 85.4% in abstract). Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 use was associated with reduced spin (odds ratio = 0.27 [95% CI = 0.13–0.57] for main text; OR = 0.39 [95% CI = 0.20–0.76] for abstract). Conclusions: There is a high prevalence of spin in systematic reviews published in rehabilitation journals. To avoid spin in the SRs of rehabilitation journals, the authors must adhere to guidelines, such as Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020.


  • Open Access

    Validity of cachexia diagnosed using AWGC criteria in outpatients with chronic kidney disease undergoing hemodialysis: a cross-sectional study

    by Takuma Yagi, Tatsuro Inoue, Masato Ogawa, Masatsugu Okamura, Kengo Shirado, Nobuyuki Shirai, Shuji Konishi, Takashi Koshiba, Yuichiro Ishigaki, Yasunori Heguri, et al.

    Background Cachexia worsens the long-term prognosis of patients with chronic kidney disease (CKD) undergoing hemodialysis. The Asian Working Group for Cachexia (AWGC) has proposed diagnostic criteria tailored to Asian populations. In this study, we aimed to validate the AWGC criteria for diagnosing cachexia in patients with CKD undergoing hemodialysis by focusing on the prevalence, diagnostic accuracy, health-related quality of life (HRQoL), and instrumental activities of daily living (IADL). Methods This cross-sectional study included 93 outpatients with CKD undergoing hemodialysis. Cachexia was diagnosed using the AWGC and Evans criteria. HRQoL was assessed using the European Quality of Life 5 Dimensions 5-level (EQ-5D-5L), and IADL was evaluated using the Lawton IADL scale. Statistical analyses included evaluation of sensitivity and specificity and multiple regression to examine the associations of cachexia definitions with HRQoL, and IADL. Results Cachexia prevalence was 30.1% and 24.7% according to the AWGC and Evans criteria, respectively. All patients diagnosed with cachexia based on the Evans criteria were also identified as having the condition based on the AWGC criteria. The AWGC criteria demonstrated superior diagnostic accuracy (κ = 0.865), with a sensitivity of 1.000 and specificity of 0.929. Associations of cachexia (as defined by each criterion) with HRQoL and IADL were similar. Conclusions In contrast to the Evans criteria, the AWGC criteria demonstrated high validity and superior applicability for diagnosing cachexia in outpatients with CKD undergoing hemodialysis. These findings highlight the practicality of the AWGC criteria. Their use may facilitate early detection and help prevent cachexia progression, thereby improving patient outcomes.

  • Open Access

    Digital health interventions for non-older individuals at risk of frailty: A systematic review and meta-analysis

    by Momoko Tohyama, Ryo Momosaki, Yuka Shirai, Kenta Ushida, Yuki Kato, Miho Shimizu, Issei Kameda, Yuya Sakurai, Asuka Hori, Masatsugu Okamura, et al.

    Objective: Frailty is a significant health problem that results in adverse outcomes, reduced quality of life, and increased medical and nursing care costs. This study aimed to review the effect of digital health interventions on improving physical activity, physical function, and social function in non-older individuals at risk of frailty. Methods: Randomized controlled trials of digital health interventions reporting frailty-related outcomes on physical activity, physical function, and social function in non-older individuals at risk of frailty were collected. The literature was reviewed, and the risk of bias was assessed. Meta-analyses were conducted for each outcome, and the certainty of evidence was assessed using Grading of Recommendations Assessment, Development, and Evaluation. Results: The review included a total of 63 records. The meta-analysis showed that digital health interventions positively affected the volume of physical activity, daily steps, walking test, walking speed, VO2peak, dynamic gait index, timed up and go test, and MOS 36-Item Short-Form Health Survey Social Functioning. However, no significant effect on the time of physical activity was found. Despite the absence of fatal bias, the overall certainty of the evidence was not high because of the small number of studies and participants included in the analysis. Conclusions: Digital health interventions can improve physical activity, physical function, and social function in non-older individuals at risk of frailty. However, the evidence had limited certainty, and the evidence supporting the effect of digital health intervention is insufficient. Thus, more studies are needed to clarify the effects of these interventions.


  • High-intensity interval training versus moderate-intensity continuous training in patients with heart failure: a systematic review and meta-analysis

    by Masatsugu Okamura, Masashi Shimizu, Shuhei Yamamoto, Kenichi Nishie, Masaaki Konishi

    The effects of high-intensity interval training (HIIT) in patients with heart failure (HF) remain controversial. This systematic review and meta-analysis aimed to examine the efficacy of HIIT versus moderate-intensity continuous aerobic training (MCT) on exercise tolerance in patients with HF. We searched for studies published up to 4 March 2022 in Embase, MEDLINE, PubMed, and the Cochrane Library with no limitations on data, language, or publication status. We included randomized controlled trials comparing the efficacy of HIIT and MCT on peak oxygen uptake (VO2), as a measure of exercise tolerance. We pooled the data on peak VO2, compared HIIT to MCT, and conducted a sub-analysis if there was heterogeneity in the result. We identified 15 randomized controlled trials with 557 patients. Our meta-analysis showed that participants who underwent HIIT achieved a significantly higher peak VO2 than those who underwent MCT (mean difference 1.46 ml/kg/min, 95% confidence interval 0.39 to 2.53; participants = 557; studies = 15; I2 = 65.7%; very low-quality evidence). The meta-regression analysis, conducted as a sub-analysis to explore possible causes of heterogeneity, revealed that the difference in peak VO2 between HIIT and MCT was inversely associated with body mass index (r = − 0.508, p = 0.028, 95% confidence interval − 0.95 to − 0.07). Our systematic review showed that HIIT achieved a higher peak VO2 than MCT in patients with HF. In addition, HIIT may be more effective in improving exercise tolerance in patients with low body mass index.


  • Top Cited Papers
    Open Access

    Kidney function in cachexia and sarcopenia: Facts and numbers

    by Masatsugu Okamura, Masaaki Konishi, Javed Butler, Kamyar Kalantar‐Zadeh, Stephan von Haehling, Stefan D. Anker

    Cachexia, in the form of unintentional weight loss >5% in 12 months or less, and secondary sarcopenia in the form of muscle wasting are serious conditions that affect clinical outcomes. A chronic disease state such as chronic kidney disease (CKD) often contributes to these wasting disorders. The purpose of this review is to summarize the prevalence of cachexia and sarcopenia, their relationship with kidney function, and indicators for evaluating kidney function in patients with CKD. It is estimated that approximately half of all persons with CKD will develop cachexia with an estimated annual mortality rate of 20%, but few studies have been conducted on cachexia in CKD. Hence, the true prevalence of cachexia in CKD and its effects on kidney function and patient outcomes remain unclear. Some studies have highlighted the concept of protein‐energy wasting (PEW) which usually include sarcopenia and cachexia. Several studies have examined kidney function and CKD progression in patients with sarcopenia. Most studies use serum creatinine levels to estimate kidney function. However, creatinine may be influenced by muscle mass, and creatinine‐based glomerular filtration rate may overestimate kidney function in patients with reduced muscle mass or muscle wasting. Cystatin C, which is least affected by muscle mass, has been used in some studies, and creatinine‐to‐cystatin‐C ratio has emerged as an important prognostic marker. A previous study incorporating 428 320 participants reported that participants with CKD and sarcopenia had a 33% higher hazard of mortality compared with those without (7% to 66%, P = 0.011), and that those with sarcopenia were twice as likely to develop end‐stage kidney disease (hazard ratio: 1.98; 1.45 to 2.70, P < 0.001). Future studies on cachexia and sarcopenia in patients with CKD are needed to report rigorously defined cachexia concerning kidney function. Moreover, in studies on sarcopenia with CKD, it is desirable to accumulate studies using cystatin C to accurately estimate kidney function.


  • Open Access

    Rehabilitation Nutrition in Patients with Chronic Kidney Disease and Cachexia

    by Masatsugu Okamura, Tatsuro Inoue, Masato Ogawa, Kengo Shirado, Nobuyuki Shirai, Takuma Yagi, Ryo Momosaki, Yoji Kokura

    Rehabilitation nutrition is a proposed intervention strategy to improve nutritional status and physical function. However, rehabilitation nutrition in patients with cachexia and protein-energy wasting (PEW), which are the main nutrition-related problems in patients with chronic kidney disease (CKD), has not been fully clarified. Therefore, this review aimed to summarize the current evidence and interventions related to rehabilitation nutrition for cachexia and PEW in patients with CKD. CKD is a serious condition worldwide, with a significant impact on patient prognosis. In addition, CKD is easily complicated by nutrition-related problems such as cachexia and PEW owing to disease background- and treatment-related factors, which can further worsen the prognosis. Although nutritional management and exercise therapy are reportedly effective for cachexia and PEW, the effectiveness of combined nutrition and exercise interventions is less clear. In the future, rehabilitation nutrition addressing the nutritional problems associated with CKD will become more widespread as more scientific evidence accumulates. In clinical practice, early intervention in patients with CKD involving both nutrition and exercise after appropriate assessment may be necessary to improve patient outcomes.


  • Open Access

    Relationship between Nutrition-Related Problems and Falls in Hemodialysis Patients: A Narrative Review

    by Nobuyuki Shirai, Tatsuro Inoue, Masato Ogawa, Masatsugu Okamura, Shinichiro Morishita, Yamamoto Suguru, Atsuhiro Tsubaki

    Falls are a social problem that increase healthcare costs. Hemodialysis (HD) patients need to avoid falling because fractures increase their risk of death. Nutritional problems such as frailty, sarcopenia, undernutrition, protein-energy wasting (PEW), and cachexia may increase the risk of falls and fractures in patients with HD. This review aimed to summarize the impact of frailty, sarcopenia, undernutrition, PEW, and cachexia on falls in HD patients. The reported global incidence of falls in HD patients is 0.85–1.60 falls per patient per year. HD patients fall frequently, but few reports have investigated the relationship between nutrition-related problems and falls. Several studies reported that frailty and undernutrition increase the risk of falls in HD patients. Nutritional therapy may help to prevent falls in HD patients. HD patients’ falls are caused by nutritional problems such as iatrogenic and non-iatrogenic factors. Falls increase a person’s fear of falling, reducing physical activity, which then causes muscle weakness and further decreased physical activity; this cycle can cause multiple falls. Further research is necessary to clarify the relationships between falls and sarcopenia, cachexia, and PEW. Routine clinical assessments of nutrition-related problems are crucial to prevent falls in HD patients.